| pubmed-article:3159517 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C0028127 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C0030040 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C0005823 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C1561560 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C1561561 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C1547135 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C1547139 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:3159517 | lifeskim:mentions | umls-concept:C0439841 | lld:lifeskim |
| pubmed-article:3159517 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:3159517 | pubmed:dateCreated | 1985-8-12 | lld:pubmed |
| pubmed-article:3159517 | pubmed:abstractText | We investigated whether beta-blockers or calcium-antagonists might be preferred in baseline antihypertensive therapy. In middle-aged male patients with essential BP readings did not differ between patients on Oxprenolol or on Nitrendipine (average BP: 123 +/- 12/81 +/- 14 vs. 129 +/- 17/80 +/- 10 mmHg), when clinical casual BP was within the normotensive range. Average BP at work was lower than clinical casual BP taken at the same day (125 +/- 14/80 +/- 12 vs. 133 +/- 12/87 +/-13 mmHg). A linear dependency between SBP at work and level of self reported physical activity (F(3,413) = 7.6; p less than or equal to 0.001) and arousal was found (F(3,374) = 5.2; p less than or equal to 0.02). Patients on Oxprenolol consistently had lower SBP at a particular level of physical activity and at lower levels of arousal than patients on Nitrendipine. We conclude that both regimen were equally effective as baseline antihypertensive monotherapy. | lld:pubmed |
| pubmed-article:3159517 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3159517 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159517 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3159517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159517 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159517 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3159517 | pubmed:issn | 0730-0077 | lld:pubmed |
| pubmed-article:3159517 | pubmed:author | pubmed-author:WagnerOO | lld:pubmed |
| pubmed-article:3159517 | pubmed:author | pubmed-author:RüddelHH | lld:pubmed |
| pubmed-article:3159517 | pubmed:author | pubmed-author:von EiffA WAW | lld:pubmed |
| pubmed-article:3159517 | pubmed:author | pubmed-author:LangewitzWW | lld:pubmed |
| pubmed-article:3159517 | pubmed:author | pubmed-author:SchmiederRR | lld:pubmed |
| pubmed-article:3159517 | pubmed:author | pubmed-author:PhamG TGT | lld:pubmed |
| pubmed-article:3159517 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3159517 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:3159517 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3159517 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3159517 | pubmed:pagination | 445-54 | lld:pubmed |
| pubmed-article:3159517 | pubmed:dateRevised | 2008-2-12 | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:meshHeading | pubmed-meshheading:3159517-... | lld:pubmed |
| pubmed-article:3159517 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3159517 | pubmed:articleTitle | The influence of monotherapy with oxprenolol and nitrendipine on ambulatory blood pressure in hypertensives. | lld:pubmed |
| pubmed-article:3159517 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3159517 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3159517 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
